4.8200
+0.1200
+(2.55%)
As of 9:30:00 AM EST. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Steven A. Ledger | CEO & Director | 237.5k | -- | 1959 |
| Dr. Randall W. Moreadith M.D., Ph.D. | Chief Development Officer | 433.88k | -- | 1955 |
| Dr. Balkrishan Gill Ph.D. | Executive Chairman | -- | -- | 1965 |
| Mr. Gregory S. Curhan | Chief Financial Officer | -- | -- | 1962 |
| Dr. Srini Tenjarla | Senior Vice President of Chemistry, Manufacturing & Controls and Formulation | -- | -- | -- |
Serina Therapeutics, Inc.
601 Genome Way
Suite 2001
Huntsville, AL 35806
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 9
Description
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Corporate Governance
Serina Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 20, 2025 at 10:59 AM UTC - March 24, 2025 at 12:00 PM UTC
Serina Therapeutics, Inc. Earnings Date
Recent Events
Related Tickers
EPRX Eupraxia Pharmaceuticals Inc.
3.0247
+3.23%
LCTX Lineage Cell Therapeutics, Inc.
0.6251
-1.71%
BT3.F Lineage Cell Therapeutics, Inc.
0.6000
+2.56%
30J.SG IDEAYA Biosciences, Inc.
21.60
0.00%
ONCIN.OL Oncoinvent ASA
2.6500
-1.85%
2511.HK HighTide Therapeutics, Inc.
1.170
+5.41%
MAAT.PA MaaT Pharma SA
8.00
-0.25%
2257.HK Sirnaomics Ltd.
2.770
-4.81%
LADX LadRx Corporation
1.7000
0.00%
MSCLF Satellos Bioscience Inc.
0.6025
0.00%